(Q48793100)

15 February 2018

title

Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice. (English)

1 reference

15 February 2018

0 references

1 reference

2

1 reference

15 February 2018

author name string

Venissa Machado

1

1 reference

15 February 2018

Richa Das

3

1 reference

15 February 2018

Andreas Schober

4

1 reference

15 February 2018

Lioudmila Bogatyreva

5

1 reference

15 February 2018

Dieter Hauschke

6

1 reference

15 February 2018

Kerstin Krieglstein

7

1 reference

15 February 2018

Klaus Unsicker

8

1 reference

15 February 2018

Björn Spittau

9

1 reference

15 February 2018

publication date

26 April 2016

1 reference

15 February 2018

published in

Cell and Tissue Research

1 reference

15 February 2018

volume

365

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

209-223

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00441-016-2406-x

exact match

0 references

cites work

The hallmarks of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Repairing the parkinsonian brain with neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Glial-mediated inflammation underlying parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Differential inflammatory activation of IL-6 (-/-) astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Neurotoxin-based models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

TGF-beta 1 is an organizer of responses to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

FGF-2 modulates dopamine and dopamine-related striatal transmitter systems in the intact and MPTP-lesioned mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Treatment of Parkinson's disease with trophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

GDF-15 prevents platelet integrin activation and thrombus formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Growth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Neurochemical findings in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Progressive postnatal motoneuron loss in mice lacking GDF-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Pathogenic role of glial cells in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

The role of glial cells in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Current advances in using neurotrophic factors to treat neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2406-X

10.1007/S00441-016-2406-X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

release_aaf2klp7bnayrprtqqeketxulm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aaf2klp7bnayrprtqqeketxulm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

27115420

1 reference

15 February 2018